Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes After Acute Myocardial Infarction
Author(s) -
Sang-Ging Ong,
Bruno Hüber,
Won Hee Lee,
Kazuki Kodo,
Antje Ebert,
Yu Ma,
Patricia K. Nguyen,
Sebastian Diecke,
Wen-Yi Chen,
Joseph C. Wu
Publication year - 2015
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.114.015231
Subject(s) - induced pluripotent stem cell , medicine , transplantation , stem cell , myocardial infarction , bioluminescence imaging , paracrine signalling , stem cell therapy , cancer research , microbiology and biotechnology , pathology , cardiology , cell culture , embryonic stem cell , luciferase , biology , genetics , gene , transfection , biochemistry , receptor
Human induced pluripotent stem cells (iPSCs) are attractive candidates for therapeutic use, with the potential to replace deficient cells and to improve functional recovery in injury or disease settings. Here, we test the hypothesis that human iPSC-derived cardiomyocytes (iPSC-CMs) can secrete cytokines as a molecular basis to attenuate adverse cardiac remodeling after myocardial infarction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom